Kaohsiung Journal of Medical Sciences
Volume 24, Issue 4 , Pages 190-196 , April 2008

Potential Risk and Protective Factors for In-Hospital Mortality in Hyperacute Ischemic Stroke Patients

  • Chien-Hsun Li

      Affiliations

    • Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Gim-Thean Khor

      Affiliations

    • Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Chun-Hung Chen

      Affiliations

    • Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Poyin Huang

      Affiliations

    • Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Ruey-Tay Lin

      Affiliations

    • Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Department of Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Corresponding Author InformationAddress correspondence and reprint requests to: Dr Ruey-Tay Lin, Department of Neurology, Kaohsiung Medical University Hospital, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan

Received 7 May 2007 ,Accepted 21 November 2007.

References 

  1. Brown RD , Whisnant JP , Sicks JD , et al.   Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989 . Stroke . 1996;27:373–380
  2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group  . Tissue plasminogen activator for acute ischemic stroke . N Engl J Med . 1995;333:1581–1587
  3. Stroke Unit Trialists' Collaboration . Organized inpatient (stroke unit) care for stroke . Cochrane Database Syst Rev . 2000;2: CD000197
  4. Alberts MJ , Hademenos G , Latchaw RE , et al.   Recommendations for the establishment of primary stroke centers . JAMA . 2000;283:3102–3109
  5. Katzan IL , Furlan AJ , Lloyd LE , et al.   Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience . JAMA . 2000;283:1151–1158
  6. Heuschmann PU , Berger K , Misselwitz B , et al.   Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group . Stroke . 2003;34:1106–1113
  7. Heuschmann PU , Kolominsky-Rabas PL , Roether J , et al.   Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy . JAMA . 2004;292:1831–1838
  8. Bateman BT , Schumacher HC , Boden-Albala B , et al.   Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002 . Stroke . 2006;37:440–446
  9. Dubinsky R , Lai SM . Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample . Neurology . 2006;66:1742–1744
  10. Elkind MS , Prabhakaran S , Pittman J , et al.   Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke . Neurology . 2007;68:842–848
  11. Leslie AG , Johnston SC . Characteristics of academic medical centers and ischemic stroke outcomes . Stroke . 2001;32:2137–2142
  12. Heuschmann PU , Kolominsky-Rabas PL , Misselwitz B , et al.   Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group . Arch Intern Med . 2004;164:1761–1768
  13. Huang Poyin  , Chen CH , Liu CK , et al.   Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke . Cerebrovasc Dis . 2006;22:423–428
  14. Wolf PA , D'Agostino RB , Belanger AJ , et al.   Probability of stroke: a risk profile from the Framingham study . Stroke . 1991;22:312–318
  15. Steiner MM , Brainin M . The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units . European Journal of Neurology . 2003;10:353–360
  16. Anthony F , Randall H , Lawrence W , et al.   Intra-arterial prourokinase for acute ischemic stroke the PROACT II study: a randomized controlled trial . JAMA . 1999;282:2003–2011
  17. Akira O , Etsuro M , Kazuo M , et al.   Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan . Stroke . 2007;38:2633–2639
  18. Sacco RL . Risk factors, outcomes, and stroke subtypes for ischemic stroke . Neurology . 1997;40:39–44
  19. Henon H , Durieu I , Lebert F , et al.   Influence of prestroke dementia on early and delayed mortality in stroke patients . J Neurol . 2003;250:10–16
  20. Weimar C , Ziegler A , Konig IR , et al.   Predicting functional outcome and survival after acute ischemic stroke . J Neurol . 2002;249:888–895
  21. Frankel MR , Morgenstern LB , Kwiatkowski T , et al.   Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial . Neurology . 2000;55:952–959
  22. Handschu R , Haslbeck M , Hartmann A , et al.   Mortality prediction in critical care for acute stroke: severity of illness-score or coma-scale . J Neurol . 2005;252:1249–1254
  23. Rordorf G , Koroshetz W , Efird JT , et al.   Predictors of mortality in stroke patients admitted to an intensive care unit . Crit Care Med . 2000;28:1301–1305
  24. Wong KS . Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: a prospective hospital-based study in Asia . Stroke . 1999;30:2326–2330
  25. Sumer MM , Ozdemir I , Tascilar N . Predictors of outcome after acute ischemic stroke . Acta Neurologica Scandinavica . 2003;107:276–280
  26. Holloway RG , Benesch CG , Burgin WS , et al.   Prognosis and decision making in severe stroke . JAMA . 2005;294:725–733

PII: S1607-551X(08)70116-5

doi: 10.1016/S1607-551X(08)70116-5

Kaohsiung Journal of Medical Sciences
Volume 24, Issue 4 , Pages 190-196 , April 2008

Article Tools